* Orgenesis Inc ORGS.OQ ORGS.O is expected to show a
fall in
quarterly revenue when it reports results on November 2
(estimated).
* The Germantown Maryland-based company is expected to
report a
15.9% decrease in revenue to $7.3 million from $8.68 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Orgenesis Inc is
for a
loss of 2 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Orgenesis
Inc is
$9, above its last closing price of $1.28.
This summary was machine generated October 31 at 18:31 GMT. All
figures in US dollars unless otherwise stated